sarpogrelate has been researched along with Critical Illness in 1 studies
sarpogrelate: structure given in first source
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)." | 7.80 | Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia. ( Iida, O; Kaneto, H; Katakami, N; Matsuoka, TA; Shimomura, I; Takahara, M, 2014) |
| " However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)." | 3.80 | Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia. ( Iida, O; Kaneto, H; Katakami, N; Matsuoka, TA; Shimomura, I; Takahara, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahara, M | 1 |
| Kaneto, H | 1 |
| Katakami, N | 1 |
| Iida, O | 1 |
| Matsuoka, TA | 1 |
| Shimomura, I | 1 |
1 other study available for sarpogrelate and Critical Illness
| Article | Year |
|---|---|
Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Critical Illness; Disease-Free Survival; Endovascular | 2014 |